These findings are consistent with a study which demonstrates that TTM treatment or the knockdown of copper transporter SLC31A1 (also called Ctr1) significantly increases the ratio of LC3B-II/I and promoted autophagy in pancreatic cancer cells [44]. Here, SLC31A1 is linked to familial pancreatic carcinoma.